Cordyceps Sunshine Biotech Holdings (RAJAF) Net Cash Flow (2022 - 2023)

Cordyceps Sunshine Biotech Holdings (RAJAF) recorded quarterly Net Cash Flow of -$3.1 million in Q4 2023, down 3589.84% quarter-over-quarter from -$83335.0 in Q4 2022, and down 3589.84% on a YoY basis from $88110.9 in Q4 2022.

Cordyceps Sunshine Biotech Holdings (RAJAF) Net Cash Flow (2022 - 2023) Analysis & Trends

Cordyceps Sunshine Biotech Holdings' Net Cash Flow history runs 2 years deep, the most recent figure standing at -$3.1 million for Q4 2023.

  • In Q4 2023, Net Cash Flow fell 3589.84% year-over-year to -$3.1 million; the TTM figure through Dec 2025 stood at -$3.1 million (up 2.64% YoY), while the FY2025 annual figure was -$35845.0, down 662.8% from the prior year.
  • Net Cash Flow was -$3.1 million for Q4 2023 at Cordyceps Sunshine Biotech Holdings, down from -$83335.0 in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of -$83335.0 in Q4 2022 to a low of -$3.1 million in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Paranovus Entertainment Technology 75,216.52 Bn 75,216.52 Bn - -
2 Kraft Heinz 26.76 Bn 22.68 Bn 2.22 Bn 679.00 Mn
3 General Mills 17.79 Bn 17.02 Bn 1.37 Bn 81.70 Mn
4 Jbs 13.93 Bn 9.37 Bn 2.32 Bn -1.03 Bn
5 Hormel Foods 13.00 Bn 12.16 Bn 518.51 Mn -42.73 Mn
6 Mccormick 12.70 Bn 13.10 Bn 708.90 Mn 70.20 Mn
7 Magnum Ice Cream 12.17 Bn 11.70 Bn - -366.67 Mn
8 J M Smucker 11.05 Bn 10.99 Bn 827.80 Mn -11.40 Mn
9 Smithfield Foods 10.57 Bn 9.49 Bn 511.00 Mn -150.00 Mn
10 Cordyceps Sunshine Biotech Holdings - - - -

Historic Data

Download Data
DateValue
Dec 31, 2023 -3.07 Mn
Dec 31, 2023 -3.07 Mn
Dec 31, 2022 -83,335.00
Dec 31, 2022 -83,335.00